Function-blocking antithrombospondin-1 monoclonal antibodies

被引:37
作者
Annis, DS
Murphy-Ullrich, JE
Mosher, DF
机构
[1] Univ Wisconsin, Dept Med, Med Sci Ctr, Madison, WI 53706 USA
[2] Univ Alabama, Dept Pathol, Cell Adhes & Matrix Res Ctr, Birmingham, AL 35294 USA
关键词
monoclonal antibody; thrombospondin; transforming growth factor-beta;
D O I
10.1111/j.1538-7836.2006.01723.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Thrombospondin-1 (TSP-1) has been implicated in many different processes based in part on inhibitory activities of anti-TSP-1 monoclonal antibodies (mAbs). Objective: To map epitopes of 13 anti-TSP-1 mAbs to individual modules or groups of modules spanning TSP-1 and the closely related TSP-2 homolog. Results: The mapping has led to assignment or reassignment of the epitopes of four mAbs, refinement of the epitopes of six mAbs, and confirmation of the epitopes of the remaining three mAbs. ESTs10, P12, and MA-II map to the N-terminal domain; 5G11, TSP127.6, and ESTs12 to the third properdin module; C6.7, HB8432, and P10 to epidermal growth factor (EGF)-like modules 1 and/or 2; and A6.1, mAb133, MA-I, and D4.6 to the calcium-binding wire module. A6.1, which recognizes a region of the wire that is identical in mouse and human TSP-1, reacts with TSP-1 from both species, and also reacts weakly with human TSP-2. Two other mouse antihuman TSP-1 mAbs, A4.1 and D4.6, also react with mouse TSP-1. Conclusions: Consideration of previous literature and mapping of epitopes of inhibitory mAbs suggest that biological activities are present throughout TSP-1, including the EGF-like modules that have not been implicated in the past. Because the epitopes for 10 of the antibodies likely are within 18 nm of one another in calcium-replete TSP-1, some of the inhibitory effects may result from steric hindrance. Such seems to be the case for mAb133, which binds the calcium-binding wire but is still able to interfere with the activation of latent TGF-beta by the properdin modules.
引用
收藏
页码:459 / 468
页数:10
相关论文
共 57 条
  • [1] CELL-TYPE-SPECIFIC ADHESIVE INTERACTIONS OF SKELETAL MYOBLASTS WITH THROMBOSPONDIN-1
    ADAMS, JC
    LAWLER, J
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1994, 5 (04) : 423 - 437
  • [2] ADAMS JC, 1993, J CELL SCI, V104, P1061
  • [3] Thrombospondins: Multifunctional regulators of cell interactions
    Adams, JC
    [J]. ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2001, 17 : 25 - 51
  • [4] Novel integrin antagonists derived from thrombospondins
    Calzada, MJ
    Roberts, DD
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (07) : 849 - 866
  • [5] Identification of novel β1 integrin binding sites in the type 1 and type 2 repeats of thrombospondin-1
    Calzada, MJ
    Annis, DS
    Zeng, BX
    Marcinkiewicz, C
    Banas, B
    Lawler, J
    Mosher, DF
    Roberts, DD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (40) : 41734 - 41743
  • [6] α4β1 integrin mediates selective endothelial cell responses to thrombospondins 1 and 2 in vitro and modulates angiogenesis in vivo
    Calzada, MJ
    Zhou, L
    Sipes, JM
    Zhang, J
    Krutzsch, HC
    Iruela-Arispe, ML
    Annis, DS
    Mosher, DF
    Roberts, DD
    [J]. CIRCULATION RESEARCH, 2004, 94 (04) : 462 - 470
  • [7] Structure of the calcium-rich signature domain of human thrombospondin-2
    Carlson, CB
    Bernstein, DA
    Annis, DS
    Misenheimer, TM
    Hannah, BLA
    Mosher, DF
    Keck, JL
    [J]. NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2005, 12 (10) : 910 - 914
  • [8] Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery
    Chen, DH
    Asahara, T
    Krasinski, K
    Witzenbichler, B
    Yang, JH
    Magner, M
    Kearney, M
    Frazier, WA
    Isner, JM
    Andrés, V
    [J]. CIRCULATION, 1999, 100 (08) : 849 - 854
  • [9] CHEN H, 1994, J BIOL CHEM, V269, P32226
  • [10] Metabolism of thrombospondin 2 - Binding and degradation by 3T3 cells and glycosaminoglycan-variant Chinese hamster ovary cells
    Chen, H
    Strickland, DK
    Mosher, DF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (27) : 15993 - 15999